StemBond Technologies
BiotechnologyView the employees at
StemBond Technologies-
Agata Nyga Head of R&D at StemBond || Improving cell therapies®enerative medicine || Research & Policy
-
Cambridge, England, United Kingdom
-
Top 5%
Andrew Hodgson Co-Founder CEO of StemBond Technologies-
Cambridge, England, United Kingdom
-
Rising Star
-
Overview
StemBond Technologies is leveraging advanced materials science to transform scalable cell culture, tissue engineering and regenerative medicine. Our physics-based solutions alleviate cell culture bottlenecks experienced by those seeking to harness cell function. With precise and reproducible control over extracellular mechanics, StemBond Technologies delivers more stable cultures, less phenotypic drift and increased uniformity.